Syndecan-1-mediated signaling events

No Pathway Network information available for Syndecan-1-mediated signaling events

Pathways in the Syndecan-1-mediated signaling events SuperPath

#	Name	Source	Genes
1	Syndecan-1-mediated signaling events	PubChem	BSG CASK CCL5 COL11A1 COL11A2 COL1A1 COL1A2 COL2A1 COL3A1 COL5A1 COL5A2 COL6A1 COL6A2 COL6A3 COL7A1 FGFR2 FGFR3 HGF HPSE LAMA5 MAPK3 MET MMP1 MMP7 MMP9 PPIB PRKACA SDC1 SDCBP TGFB1 (see all 30) (see less)

Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways

#	Symbol	Description	Category	# Related Pathways
1	COL6A2	Collagen Type VI Alpha 2 Chain	Protein Coding	1
2	COL5A1	Collagen Type V Alpha 1 Chain	Protein Coding	1
3	COL5A2	Collagen Type V Alpha 2 Chain	Protein Coding	1
4	COL3A1	Collagen Type III Alpha 1 Chain	Protein Coding	1
5	COL11A2	Collagen Type XI Alpha 2 Chain	Protein Coding	1
6	COL6A1	Collagen Type VI Alpha 1 Chain	Protein Coding	1
7	COL11A1	Collagen Type XI Alpha 1 Chain	Protein Coding	1
8	COL7A1	Collagen Type VII Alpha 1 Chain	Protein Coding	1
9	COL6A3	Collagen Type VI Alpha 3 Chain	Protein Coding	1
10	COL2A1	Collagen Type II Alpha 1 Chain	Protein Coding	1
11	COL1A1	Collagen Type I Alpha 1 Chain	Protein Coding	1
12	FGFR3	Fibroblast Growth Factor Receptor 3	Protein Coding	1
13	FGFR2	Fibroblast Growth Factor Receptor 2	Protein Coding	1
14	CCL5	C-C Motif Chemokine Ligand 5	Protein Coding	1
15	COL1A2	Collagen Type I Alpha 2 Chain	Protein Coding	1
16	HGF	Hepatocyte Growth Factor	Protein Coding	1
17	SDC1	Syndecan 1	Protein Coding	1
18	HPSE	Heparanase	Protein Coding	1
19	LAMA5	Laminin Subunit Alpha 5	Protein Coding	1
20	MMP1	Matrix Metallopeptidase 1	Protein Coding	1
21	MMP7	Matrix Metallopeptidase 7	Protein Coding	1
22	CASK	Calcium/Calmodulin Dependent Serine Protein Kinase	Protein Coding	1
23	SDCBP	Syndecan Binding Protein	Protein Coding	1
24	MAPK3	Mitogen-Activated Protein Kinase 3	Protein Coding	1
25	MET	MET Proto-Oncogene, Receptor Tyrosine Kinase	Protein Coding	1
26	PRKACA	Protein Kinase CAMP-Activated Catalytic Subunit Alpha	Protein Coding	1
27	BSG	Basigin (Ok Blood Group)	Protein Coding	1
28	PPIB	Peptidylprolyl Isomerase B	Protein Coding	1
29	MMP9	Matrix Metallopeptidase 9	Protein Coding	1
30	TGFB1	Transforming Growth Factor Beta 1	Protein Coding	1

Disorders associated with Syndecan-1-mediated signaling events SuperPath

according to GeneCards Suite gene sharing

#	Disorder	Type	Genes	Score
1	Ehlers-danlos syndrome, classic type, 1	Enrichment	COL1A1, COL1A2, COL5A1, COL5A2	9.50
2	Classic ehlers-danlos syndrome	Enrichment	COL1A1, COL1A2, COL5A1, COL5A2	9.50
3	Ehlers-danlos syndrome	Enrichment	COL1A1, COL1A2, COL3A1, COL5A1, COL5A2	9.35
4	Collagen vi-related dystrophies	Enrichment	COL6A1, COL6A2, COL6A3	8.01
5	Intermediate collagen vi-related muscular dystrophy	Enrichment	COL6A1, COL6A2, COL6A3	8.01
6	Bethlem muscular dystrophy	Enrichment	COL6A1, COL6A2, COL6A3	7.41
7	Ullrich congenital muscular dystrophy 1a	Enrichment	COL6A1, COL6A2, COL6A3	7.01
8	Bethlem myopathy 1a	Enrichment	COL6A1, COL6A2, COL6A3	6.47
9	Osteogenesis imperfecta, type ii	Enrichment	COL1A1, COL1A2, PPIB	6.47
10	Connective tissue disease	Enrichment	COL11A1, COL2A1, COL5A1, FGFR3	6.17
11	Primary bone dysplasia	Enrichment	COL1A1, COL1A2, FGFR3	5.94
12	Osteochondrodysplasia	Enrichment	COL1A1, COL1A2, FGFR3	5.80
13	Familial thoracic aortic aneurysm and aortic dissection	Enrichment	COL1A1, COL3A1, COL5A1, COL5A2	5.61
14	Osteogenesis imperfecta, type iv	Enrichment	COL1A1, COL1A2, PPIB	5.56
15	Osteogenesis imperfecta, type iii	Enrichment	COL1A1, COL1A2, PPIB	5.36
16	Otospondylomegaepiphyseal dysplasia, autosomal recessive	Enrichment	COL11A2, COL2A1	5.33
17	Otospondylomegaepiphyseal dysplasia, autosomal dominant	Enrichment	COL11A2, COL2A1	5.33
18	Ehlers-danlos syndrome, arthrochalasia type, 2	Enrichment	COL1A1, COL1A2	5.33
19	Fibrochondrogenesis	Enrichment	COL11A1, COL11A2	5.33
20	Recessive dystrophic epidermolysis bullosa	Enrichment	COL7A1, MMP1	5.33
21	Stickler syndrome, type ii	Enrichment	COL11A1, COL1A1	5.33
22	Ehlers-danlos/osteogenesis imperfecta syndrome	Enrichment	COL1A1, COL1A2	5.33
23	Crouzon syndrome	Enrichment	FGFR2, FGFR3	4.85
24	Lacrimoauriculodentodigital syndrome 1	Enrichment	FGFR2, FGFR3	4.85
25	Telecanthus	Enrichment	COL11A1, COL5A2	4.85
26	Ehlers-danlos syndrome, classic type, 2	Enrichment	COL5A1, COL5A2	4.85
27	High bone mass osteogenesis imperfecta	Enrichment	COL1A1, COL1A2	4.85
28	Brittle bone disorder	Enrichment	COL1A1, COL1A2, PPIB	4.78
29	Ehlers-danlos syndrome, arthrochalasia type, 1	Enrichment	COL1A1, COL1A2	4.55
30	Saethre-chotzen syndrome	Enrichment	FGFR2, FGFR3	4.55
31	Osteogenesis imperfecta with normal sclerae, dominant form	Enrichment	COL1A1, COL1A2	4.55
32	Hemifacial hyperplasia	Enrichment	FGFR2, FGFR3	4.33
33	Osteogenesis imperfecta, type i	Enrichment	COL1A1, COL1A2	4.15
34	Keratoconus	Enrichment	COL1A1, COL5A2	4.15
35	Myopathy	Enrichment	COL6A1, COL6A2, COL6A3	4.04
36	Nevus, epidermal	Enrichment	COL7A1, FGFR3	4.01
37	Hypertelorism	Enrichment	COL11A1, COL1A1, FGFR2	3.70
38	Stickler syndrome	Enrichment	COL11A1, COL2A1	3.68
39	Osteoporosis	Enrichment	COL1A1, COL1A2	3.37
40	Myopia	Enrichment	COL11A1, COL2A1	3.31
41	Beckwith-wiedemann syndrome	Enrichment	COL6A1, COL7A1	3.15
42	Heart, malformation of	Enrichment	COL11A2, COL2A1	3.15
43	Craniosynostosis	Enrichment	FGFR2, FGFR3	3.06
44	Colorectal cancer	Enrichment	FGFR2, FGFR3, MET	3.04
45	Hepatoblastoma	Enrichment	COL7A1, FGFR3	3.01
46	Rare autosomal recessive non-syndromic sensorineural deafness type dfnb	Enrichment	COL11A2, HGF, MET	3.01
47	Stickler syndrome, type i	Enrichment	COL2A1	2.66
48	Hypochondroplasia	Enrichment	FGFR3	2.66
49	Beare-stevenson cutis gyrata syndrome	Enrichment	FGFR2	2.66
50	Epidermolysis bullosa dystrophica, pretibial	Enrichment	COL7A1	2.66
51	Epidermolysis bullosa dystrophica, autosomal dominant	Enrichment	COL7A1	2.66
52	Epiphyseal dysplasia, multiple, with myopia and conductive deafness	Enrichment	COL2A1	2.66
53	Thanatophoric dysplasia, type i	Enrichment	FGFR3	2.66
54	Ehlers-danlos syndrome, cardiac valvular type	Enrichment	COL1A2	2.66
55	Epidermolysis bullosa dystrophica, autosomal recessive	Enrichment	COL7A1	2.66
56	Spondylometaphyseal dysplasia, algerian type	Enrichment	COL2A1	2.66
57	Muenke syndrome	Enrichment	FGFR3	2.66
58	Deafness, autosomal recessive 53	Enrichment	COL11A2	2.66
59	Osteoarthritis with mild chondrodysplasia	Enrichment	COL2A1	2.66
60	Avascular necrosis of femoral head, primary, 1	Enrichment	COL2A1	2.66
61	Czech dysplasia	Enrichment	COL2A1	2.66
62	Nail disorder, nonsyndromic congenital, 8	Enrichment	COL7A1	2.66
63	Deafness, autosomal recessive 39	Enrichment	HGF	2.66
64	Scaphocephaly, maxillary retrusion, and impaired intellectual development	Enrichment	FGFR2	2.66
65	Marshall syndrome	Enrichment	COL11A1	2.66
66	Kniest dysplasia	Enrichment	COL2A1	2.66
67	Apert syndrome	Enrichment	FGFR2	2.66
68	Transient bullous dermolysis of the newborn	Enrichment	COL7A1	2.66
69	Platyspondylic lethal skeletal dysplasia, torrance type	Enrichment	COL2A1	2.66
70	Epidermolysis bullosa with congenital localized absence of skin and deformity of nails	Enrichment	COL7A1	2.66
71	Fibrochondrogenesis 1	Enrichment	COL11A1	2.66
72	Thanatophoric dysplasia, type ii	Enrichment	FGFR3	2.66
73	Spondyloepiphyseal dysplasia, stanescu type	Enrichment	COL2A1	2.66
74	Camptodactyly, tall stature, and hearing loss syndrome	Enrichment	FGFR3	2.66
75	Bent bone dysplasia syndrome 1	Enrichment	FGFR2	2.66
76	Acrogeria, gottron type	Enrichment	COL3A1	2.66
77	Achondrogenesis, type ii	Enrichment	COL2A1	2.66
78	Nephrotic syndrome, type 26	Enrichment	LAMA5	2.66
79	Ullrich congenital muscular dystrophy 1b	Enrichment	COL6A2	2.66
80	Combined osteogenesis imperfecta and ehlers-danlos syndrome 2	Enrichment	COL1A2	2.66
81	Osteofibrous dysplasia	Enrichment	MET	2.66
82	Spondyloperipheral dysplasia	Enrichment	COL2A1	2.66
83	Myosclerosis, autosomal recessive	Enrichment	COL6A2	2.66
84	Ullrich congenital muscular dystrophy 1c	Enrichment	COL6A3	2.66
85	Deafness, autosomal dominant 37	Enrichment	COL11A1	2.66
86	Deafness, autosomal dominant 13	Enrichment	COL11A2	2.66
87	Deafness, autosomal recessive 97	Enrichment	MET	2.66
88	Crouzon syndrome with acanthosis nigricans	Enrichment	FGFR3	2.66
89	Epidermolysis bullosa pruriginosa	Enrichment	COL7A1	2.66
90	Autism 9	Enrichment	MET	2.66
91	Stickler syndrome, type i, nonsyndromic ocular	Enrichment	COL2A1	2.66
92	Fibrochondrogenesis 2	Enrichment	COL11A2	2.66
93	Pigmented nodular adrenocortical disease, primary, 4	Enrichment	PRKACA	2.66
94	Dystonia 27	Enrichment	COL6A3	2.66
95	Thyroid gland disease	Enrichment	COL7A1	2.66
96	Achondroplasia, severe, with developmental delay and acanthosis nigricans	Enrichment	FGFR3	2.66
97	Cardioacrofacial dysplasia 1	Enrichment	PRKACA	2.66
98	Qualitative or quantitative defects of collagen 6	Enrichment	COL6A2	2.66
99	Bent bone dysplasia syndrome 2	Enrichment	LAMA5	2.66
100	Vitreoretinopathy with phalangeal epiphyseal dysplasia	Enrichment	COL2A1	2.66
101	Recessive dystrophic epidermolysis bullosa-generalized other	Enrichment	COL7A1	2.66
102	Asphyxia neonatorum	Enrichment	COL1A1	2.66
103	Bethlem myopathy 1b	Enrichment	COL6A2	2.66
104	Arthrogryposis, distal, type 11	Enrichment	MET	2.66
105	Lacrimoauriculodentodigital syndrome 2	Enrichment	FGFR3	2.66
106	Bethlem myopathy 1c	Enrichment	COL6A3	2.66
107	Cask-related intellectual disability	Enrichment	CASK	2.66
108	Autosomal dominant rhegmatogenous retinal detachment	Enrichment	COL2A1	2.66
109	Multiple epiphyseal dysplasia with myopia and deafness	Enrichment	COL2A1	2.66
110	Hypochondrogenesis	Enrichment	COL2A1	2.66
111	Fgfr3-related chondrodysplasia	Enrichment	FGFR3	2.66
112	Pneumothorax	Enrichment	COL5A1	2.66
113	Localized dystrophic epidermolysis bullosa, acral form	Enrichment	COL7A1	2.66
114	Camptodactyly-tall stature-scoliosis-hearing loss syndrome	Enrichment	FGFR3	2.66
115	Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome	Enrichment	COL11A1	2.66
116	Dysspondyloenchondromatosis	Enrichment	COL2A1	2.66
117	Cystic lymphangioma	Enrichment	COL11A2	2.66
118	Abdominal aortic aneurysm	Enrichment	COL3A1	2.66
119	Recessive dystrophic epidermolysis bullosa inversa	Enrichment	COL7A1	2.66
120	Type 2 collagen-related bone disorder	Enrichment	COL2A1	2.66
121	Lama5-related multisystemic syndrome	Enrichment	LAMA5	2.66
122	Non-syndromic unicoronal craniosynostosis	Enrichment	FGFR2	2.66
123	Generalized dominant dystrophic epidermolysis bullosa	Enrichment	COL7A1	2.66
124	Ehlers-danlos syndrome, vascular type	Enrichment	COL3A1	2.35
125	Epiphyseal dysplasia, multiple, 1	Enrichment	COL1A1	2.35
126	Ehlers-danlos syndrome, hypermobility type	Enrichment	COL3A1	2.35
127	Camurati-engelmann disease 1	Enrichment	TGFB1	2.35
128	Spondyloepimetaphyseal dysplasia, strudwick type	Enrichment	COL2A1	2.35
129	Spondylometaphyseal dysplasia, corner fracture type	Enrichment	COL2A1	2.35
130	Osteogenesis imperfecta, type ix	Enrichment	PPIB	2.35
131	Bruck syndrome 1	Enrichment	COL1A2	2.35
132	Fg syndrome 4	Enrichment	CASK	2.35
133	Dermatofibrosarcoma protuberans	Enrichment	COL1A1	2.35
134	Cervical cancer	Enrichment	FGFR3	2.35
135	Aural atresia, congenital	Enrichment	FGFR2	2.35
136	Legg-calve-perthes disease	Enrichment	COL2A1	2.35
137	Keratosis, seborrheic	Enrichment	FGFR3	2.35
138	Pfeiffer syndrome	Enrichment	FGFR2	2.35
139	Jackson-weiss syndrome	Enrichment	FGFR2	2.35
140	Antley-bixler syndrome without genital anomalies or disordered steroidogenesis	Enrichment	FGFR2	2.35
141	Combined osteogenesis imperfecta and ehlers-danlos syndrome 1	Enrichment	COL1A1	2.35
142	Fibromuscular dysplasia, multifocal	Enrichment	COL5A1	2.35
143	Polymicrogyria with or without vascular-type ehlers-danlos syndrome	Enrichment	COL3A1	2.35
144	Inflammatory bowel disease, immunodeficiency, and encephalopathy	Enrichment	TGFB1	2.35
145	Childhood hepatocellular carcinoma	Enrichment	MET	2.35
146	Aortic dissection	Enrichment	COL3A1	2.35
147	Split hand-foot malformation	Enrichment	FGFR2	2.35
148	Syndromic x-linked intellectual disability	Enrichment	CASK	2.35
149	Papillary renal cell carcinoma	Enrichment	MET	2.35
150	Camurati-engelmann disease	Enrichment	TGFB1	2.35
151	Metaphyseal anadysplasia 2	Enrichment	MMP9	2.35
152	Fibrolamellar carcinoma	Enrichment	PRKACA	2.35
153	Familial avascular necrosis of the femoral head	Enrichment	COL2A1	2.35
154	Cervix carcinoma	Enrichment	FGFR3	2.35
155	Metaphyseal anadysplasia	Enrichment	MMP9	2.35
156	Autosomal dominant nonsyndromic deafness	Enrichment	FGFR2	2.35
157	Dentinogenesis imperfecta	Enrichment	COL1A2	2.35
158	Epidermolysis bullosa dystrophica	Enrichment	COL7A1	2.35
159	Sensorineural hearing loss	Enrichment	COL11A2, HGF	2.30
160	Rare autosomal dominant non-syndromic sensorineural deafness type dfna	Enrichment	COL11A1, COL11A2	2.23
161	Achondroplasia	Enrichment	FGFR3	2.18
162	Mccune-albright syndrome	Enrichment	COL2A1	2.18
163	Larsen syndrome	Enrichment	FGFR3	2.18
164	Spondyloepiphyseal dysplasia congenita	Enrichment	COL2A1	2.18
165	Megalocornea	Enrichment	COL11A1	2.18
166	Nail disorder, nonsyndromic congenital, 4	Enrichment	COL7A1	2.18
167	Hypophosphatasia, infantile	Enrichment	COL11A2	2.18
168	Intellectual developmental disorder with microcephaly and pontine and cerebellar hypoplasia	Enrichment	CASK	2.18
169	Caffey disease	Enrichment	COL1A1	2.18
170	Syndromic x-linked intellectual disability najm type	Enrichment	CASK	2.18
171	Cerebellar disease	Enrichment	CASK	2.18
172	Hamartoma	Enrichment	FGFR3	2.18
173	Testicular germ cell cancer	Enrichment	FGFR3	2.18
174	Spermatocytoma	Enrichment	FGFR3	2.18
175	Renal cell carcinoma	Enrichment	MET	2.18
176	Multiple epiphyseal dysplasia	Enrichment	COL2A1	2.18
177	Testicular cancer	Enrichment	FGFR3	2.18
178	Hyperpigmentation of the skin	Enrichment	COL7A1	2.18
179	Phenylketonuria	Enrichment	COL1A1	2.05
180	Epidermolytic hyperkeratosis	Enrichment	COL7A1	2.05
181	Non-syndromic bicoronal craniosynostosis	Enrichment	FGFR3	2.05
182	Glioma	Enrichment	FGFR2	2.05
183	Epidermolytic hyperkeratosis 1	Enrichment	COL7A1	1.96
184	Retinal detachment	Enrichment	COL2A1	1.96
185	Anemia, congenital, nonspherocytic hemolytic, 1	Enrichment	CASK	1.96
186	Epidermolysis bullosa	Enrichment	COL7A1	1.96
187	Familial cerebral saccular aneurysm	Enrichment	COL3A1	1.96
188	Developmental dysplasia of the hip 1	Enrichment	COL2A1	1.88
189	Split-hand/foot malformation 1	Enrichment	FGFR2	1.88
190	Testicular germ cell tumor	Enrichment	FGFR3	1.88
191	Inflammatory bowel disease 25, autosomal recessive	Enrichment	TGFB1	1.88
192	Inguinal hernia	Enrichment	COL5A1	1.88
193	Pain disorder	Enrichment	COL5A1	1.88
194	Il10-related early-onset inflammatory bowel disease	Enrichment	TGFB1	1.88
195	Lung squamous cell carcinoma	Enrichment	FGFR3	1.88
196	46,xy disorder of sex development	Enrichment	FGFR3	1.88
197	Intervertebral disc disease	Enrichment	COL11A1	1.81
198	Renal cell carcinoma, papillary, 1	Enrichment	MET	1.81
199	Multiple enchondromatosis, maffucci type	Enrichment	COL2A1	1.81
200	Arthrogryposis, distal, type 1a	Enrichment	MET	1.76
201	Gastroesophageal reflux	Enrichment	COL5A1	1.76
202	Spastic paraplegia 4, autosomal dominant	Enrichment	COL3A1	1.76
203	Orthostatic intolerance	Enrichment	COL5A1	1.76
204	Ellis-van creveld syndrome	Enrichment	PRKACA	1.70
205	Familial thoracic aortic aneurysm and dissection	Enrichment	COL3A1	1.70
206	Marfan syndrome	Enrichment	COL2A1	1.66
207	Meier-gorlin syndrome 1	Enrichment	FGFR2	1.66
208	Congenital nervous system abnormality	Enrichment	CASK, FGFR3	1.64
209	Nervous system disease	Enrichment	CASK, FGFR3	1.64
210	Ichthyosis	Enrichment	COL7A1	1.62
211	Presynaptic congenital myasthenic syndromes	Enrichment	LAMA5	1.62
212	Renal hypodysplasia/aplasia 3	Enrichment	FGFR3	1.58
213	Cutis laxa	Enrichment	COL5A1	1.58
214	Clubfoot, congenital, with or without deficiency of long bones and/or mirror-image polydactyly	Enrichment	COL5A1	1.55
215	Clubfoot	Enrichment	COL5A1	1.55
216	Microcephaly	Enrichment	CASK, COL7A1	1.52
217	Multiple sclerosis	Enrichment	LAMA5	1.52
218	Aortic aneurysm, familial thoracic 1	Enrichment	COL3A1	1.52
219	Cataract	Enrichment	COL5A1	1.52
220	Renal cell carcinoma, nonpapillary	Enrichment	MET	1.49
221	Hydrocephalus	Enrichment	FGFR2	1.49
222	Cerebellar hypoplasia/atrophy, epilepsy, and global developmental delay	Enrichment	CASK	1.46
223	Gliosarcoma	Enrichment	FGFR3	1.46
224	Isolated congenital microcephaly	Enrichment	CASK	1.46
225	Cleft palate, isolated	Enrichment	COL11A1	1.43
226	Giant cell glioblastoma	Enrichment	FGFR3	1.43
227	Human immunodeficiency virus type 1	Enrichment	CCL5	1.41
228	Early infantile developmental and epileptic encephalopathy	Enrichment	CASK	1.41
229	Endometrial cancer	Enrichment	FGFR2	1.34
230	Hepatocellular carcinoma	Enrichment	MET	1.32
231	Skin disease	Enrichment	COL7A1	1.32
232	Ear malformation	Enrichment	COL11A2	1.29
233	Scoliosis	Enrichment	COL2A1	1.29
234	Muscular dystrophy	Enrichment	COL6A2	1.29
235	Bladder cancer	Enrichment	FGFR3	1.21
236	Stargardt disease 1	Enrichment	COL2A1	1.19
237	Lung cancer	Enrichment	MET	1.16
238	Cystic fibrosis	Enrichment	TGFB1	1.16
239	Genetic steroid-resistant nephrotic syndrome	Enrichment	LAMA5	1.14
240	Dystonia	Enrichment	CASK	1.13
241	Non-syndromic x-linked intellectual disability	Enrichment	CASK	1.12
242	Nonsyndromic hearing loss	Enrichment	COL11A2	1.05
243	Gastric cancer	Enrichment	FGFR2	1.04
244	Nephrotic syndrome	Enrichment	LAMA5	1.04
245	Myeloma, multiple	Enrichment	FGFR3	0.93
246	Hereditary retinal dystrophy	Enrichment	COL11A2, COL2A1	0.87
247	Fundus dystrophy	Enrichment	COL11A2, COL2A1	0.87
248	Autism	Enrichment	COL11A1	0.83
249	Rare genetic deafness	Enrichment	COL11A2	0.79
250	Ovarian cancer	Enrichment	MET	0.70
251	Inherited cancer-predisposing syndrome	Enrichment	MET	0.59

¹ WikiPathways

² PubChem

³ R&D Systems

⁴ Reactome

⁵ GeneGo (Thomson Reuters)

⁶ QIAGEN

⁷ PharmGKB

⁸ Cell Signaling Technology

⁹ Sino Biological

¹⁰ Tocris

¹¹ MalaCards

Syndecan-1-mediated signaling events

Pathway Network for Syndecan-1-mediated signaling events

Member Pathways for Syndecan-1-mediated signaling events

Pathways in the Syndecan-1-mediated signaling events SuperPath

Associated Genes for Syndecan-1-mediated signaling events

Associated Disorders for Syndecan-1-mediated signaling events

Disorders associated with Syndecan-1-mediated signaling events SuperPath

STRING Interaction Network for Syndecan-1-mediated signaling events

Sources for Syndecan-1-mediated signaling events